• Increase font size
  • Default font size
  • Decrease font size

Flanders Names Tom Justice Chief Operating Officer

Print E-mail
Tuesday, 14 July 2009 08:27

WASHINGTON, NC-- Flanders Corporation (NASDAQ: FLDR) has appointed industry veteran Tom Justice, 56, as its new Chief Operating Officer.

Harry Smith, CEO and Chairman of the Board, stated, "We are very pleased to have Tom join Flanders. A 28-year veteran of the air filtration industry, Tom brings tremendous experience in operations management and product development. He will play an integral role in our efforts to grow revenue and improve profitability, strengthening our ability to achieve operational excellence and to develop innovative new products."

A leader in the air filtration industry, Justice serves on several industry related technical committees, including the Underwriters Lab Standards Technical Panel for UL 900. He is also a member of ASHRAE, NAFA and the American Filtration Society.

Justice most recently served as Senior Applications Engineer in the Engineered Products Division of Johns Manville. Prior to joining Johns Manville in December 2007, he consulted with various companies in the air filtration industry, including Flanders, after having served 24 years at Purolator (later Clarcor Air Filtration) in several roles including plant manager, Director of Engineering and VP of Operations. Justice earned his B.S. in Mechanical Engineering from N.C. State University.

About Flanders

Flanders is a leading air filtration products manufacturer. Flanders' products are utilized by many industries, including those associated with commercial and residential heating, ventilation and air conditioning systems, semiconductor manufacturing, ultra-pure materials, biotechnology, pharmaceuticals, synthetics, nuclear power and nuclear materials processing. For further information on Flanders and its products, visit its web site at http://www.flanderscorp.com/ or contact Kirsten Chapman or Tim Dien at (415) 433-3777.





BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 
about 4 hours ago Medtronic Receives Notification of Activities Relating to INFUSE Bone Graft; FDA Receives Repros' Submission And... http://t.co/vTjySscD
about 17 hours ago OraSure In-Home HIV Test Kit Moves Closer to FDA Approval http://t.co/3apZYJHb
about 17 hours ago USA boosts Alzheimer's funding as prevention trial is launched: http://t.co/6HGiQuIu
about 17 hours ago How payers, pharmas are experimenting with outcomes based reimbursement http://t.co/aV10VjPJ
about 18 hours ago Will Mayo v. Prometheus Fire Up Pharma?: Kevin DeGeeter: Newly discovered biomarkers could provide physicians wi... http://t.co/doXumsu8
about 23 hours ago Sugar makes you stupid: Study shows high-fructose diet sabotages learning, memory http://t.co/TuGuFq1F
about 23 hours ago 'Fat tax' - http://t.co/8M5qcfp0
about 23 hours ago Nice approves prostate cancer drug - Health News - Health & Families - The Independent http://t.co/A8HSYzEd

navigation

Free Phone Trade Alerts

Benzinga.com supporter Seeking Alpha Certified